Your SlideShare is downloading. ×
Emerging Markets for In Vitro Diagnostics (IVD in Brazil, Russia, India, China and Other Nations)
Emerging Markets for In Vitro Diagnostics (IVD in Brazil, Russia, India, China and Other Nations)
Emerging Markets for In Vitro Diagnostics (IVD in Brazil, Russia, India, China and Other Nations)
Emerging Markets for In Vitro Diagnostics (IVD in Brazil, Russia, India, China and Other Nations)
Emerging Markets for In Vitro Diagnostics (IVD in Brazil, Russia, India, China and Other Nations)
Emerging Markets for In Vitro Diagnostics (IVD in Brazil, Russia, India, China and Other Nations)
Emerging Markets for In Vitro Diagnostics (IVD in Brazil, Russia, India, China and Other Nations)
Emerging Markets for In Vitro Diagnostics (IVD in Brazil, Russia, India, China and Other Nations)
Emerging Markets for In Vitro Diagnostics (IVD in Brazil, Russia, India, China and Other Nations)
Emerging Markets for In Vitro Diagnostics (IVD in Brazil, Russia, India, China and Other Nations)
Emerging Markets for In Vitro Diagnostics (IVD in Brazil, Russia, India, China and Other Nations)
Emerging Markets for In Vitro Diagnostics (IVD in Brazil, Russia, India, China and Other Nations)
Emerging Markets for In Vitro Diagnostics (IVD in Brazil, Russia, India, China and Other Nations)
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Emerging Markets for In Vitro Diagnostics (IVD in Brazil, Russia, India, China and Other Nations)

2,158

Published on

Published in: Business, Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
2,158
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
45
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Get more info on this report!Emerging Markets for In Vitro Diagnostics (IVD in Brazil, Russia, India,China and Other Nations)June 1, 2011There is much discussion about emerging markets in in vitro diagnostics, especially theBRIC nations - Brazil, Russia, India and China. Which companies have been successfulin these markets and how have they accomplished it? What kind of realistic growth canmarketers expect by selling products in these areas? This report is intended to providean overview of trends and developments in the in IVD industry as it applies to emergingmarkets and the BRIC countries in particular. A Realistic Look at the Market for IVD in New, Emerging MarketsA good number of reports on the BRIC and emerging markets have been published.Most of these focus on quantitative data such as number of labs, hospitals, productregistration regulations, and import taxes and conditions. Too many of them perhapspresent merely a growth scenario without presenting the challenges the nations faceand the challenges the countries face entering the market. This report provides much ofthis information because it provides an objective overview of the market for in vitrodiagnostics in selected countries. This report also explores the opportunities thatspecific developing countries offer to IVD companies.Kalorama also attempts to add some realistic aspects of working in a foreign countrythat are more qualitative in nature. Thus the report explores some of the culturalaspects of how the market for clinical diagnostics may evolve in a selection of emergingmarkets including the BRIC countries. Useful Information for Business PlanningThe discussion of each of the BRIC markets begins with a short introduction to thecountry and follows with a SWOT analysis of the market for IVDs. The SWOT analysisprovides positive and negative aspects of market conditions. The author has decided toinclude positive and negative aspects of certain factors in the same SWOT category.The factors are classed positive or negative according to the strength of current market
  • 2. conditions. This is done to make the analysis comprehensive and easier to read. Thereport covers data trends and issues, including: Healthcare trends and metrics in each country Physician Office Testing (POL) in BRIC Countries Disease Trends ( Diabetes, Cancer, Allergy, Emerging Viruses ) Lab Systems in BRIC Countries SWOT Analysis for Each BRIC Nation, Including: o Strengths - factors that make the country attractive for IVD companies o Weaknesses that form barriers to entry and success such as health insurance coverage, regulatory affairs and distribution issues o Country Elements that Provide Testing Opportunities o Threats - a look at the competition and incumbents Key Companies Operating in Each Country Research and High Technology in BRIC countries Other Trends (Insurance, Medical Tourism, Recession Effects )Market and economic trends are discussed from the point of view of their present andpotential impact and there is a focus on the mix of economics, healthcare anddiagnostics that may evolve in these countries. Beyond BRICWith all the attention directed at the BRIC countries, there is a tendency to think thatthey are the only prospects for IVD market growth and development. The fact is thatsome of the same trends - growing middle class, mix of infectious and non-communicable diseases and government supported healthcare - are prevalent in manycountries in E. Europe and Africa. We provide as an example three non-BRIC nations:Turkey, Poland and Nigeria, where IVD may flourish in the future. From Kalorama Information, a Respected Source for IVD Market AnalysisAuthored by Shara Rosen, R.T. MBA, the author of The Worldwide Market for In VitroDiagnostics, in seven editions, This report explores some of the quantitative andqualitative aspects of emerging markets but leaves conclusions up to the readers, whocan best judge how their individual company culture and strategic aspirations fit withprospects in emerging countries. The information contained here provides an overviewof the general economic and infrastructure information related to emerging markets. Theinformation presented in this report is derived from publicly available informationsources such as company, government, and medical organization reports. The analysisis based on the authors industry knowledge combined with literature searches andinterviews with industry professionals and experts in in vitro diagnostics.Additional Information
  • 3. IVD Sales in BRIC Nations Growing Fast, But Not Without ChallengesThe growing economies of the so-called BRIC Nations--Brazil, Russia, India andChina--will see increased demand for healthcare services led by testing. Healthcaremarket research publisher Kalorama Information notes that this is good news fordiagnostic companies. According to its report, Emerging Markets for In Vitro Diagnostics(IVD in Brazil, Russia, India, China and Other Nations), IVD sales in BRIC nations areexpected to grow from $2.9 billion in 2009 to $5 billion in 2014, which represents aCAGR of 12%.This rate of growth for diagnostic instrumentation, product and reagent sales is doublethe six percent growth rate projected for worldwide IVD sales. Kalorama suggests thatthis growth is partially occurring because as the economies of these nations grow, theycan treat a broader set of diseases than the infectious disease treatments oftenprovided by large donor organizations, and treat patients that are not properly servicednow."It is now recognized that its the low- and middle-income countries that face thegreatest burden of chronic diseases such as diabetes, heart disease and cancer," saidShara Rosen, R.T. MBA, author of the report. "As markets in industrialized countriesbegin to mature, IVD companies are casting their nets in developing countries, whererising incomes and standards of living have sparked a new health consciousness and agrowing demand for quality medical care."According to Kalorama, the IVD market in BRIC countries is dominated by establishedplayers such as Roche, Abbott, Siemens, Beckman Coulter, and Becton Dickinson.However, domestic players such as Transasia, JMitra, Horiba, Kehua, Mindray andothers have taken the distribution of IVD products from urban areas to the rural areas intheir respective markets. Incumbent companies--international and local alike--tend toprovide a host of routine tests. It is expected that as IVD demand in developingcountries increases, there will be opportunities for rapid tests and advanced tests thatare now emerging as healthcare systems become more sophisticated.Despite the strong growth rate, the report stresses that opportunities for diagnosticcompanies in BRIC nations will take some time to develop. The report also takes note offinancial and infrastructure challenges that will present obstacles to companiesmarketing in the BRIC nations and other emerging markets. Economic growth forinstance, would not make every citizen of the BRIC countries a customer."Economic growth does not always mean that the new found resources will be sharedby all socioeconomic groups in the country," said Rosen. "The reality is that althoughthere are many wealthy people who can afford the type of healthcare services that areavailable in the U.S. and in Europe, there are many more people who barely earnenough to feed themselves and their families."
  • 4. More General In Vitro Diagnostics Reports by Kalorama InformationWomens Health Diagnostic Testing Markets by Kalorama InformationEven though slightly more than half of the US population is female, medical researchhistorically has neglected the health needs of women, other than reproductive ...Kalorama 2010 Ultra Diagnostics Research Bundle by Kalorama InformationThis bundle provides customers with three of the most intensely researched KaloramaInformation reports covering the diagnostic industry authored by Shara Rosen, R.T.,M.B.A. in ...Kalorama US Healthcare Industry Overview (Pharmaceutical, Medical Device,Diagnostics and IT Markets) by Kalorama InformationKalorama Information reports on a wide range of topics related to healthcare industrymarkets in the United States. This report, The Kalorama U.S. Healthcare ...Physician Office Laboratory (POL) Testing Markets Worldwide: Status Quo and FutureTrends by Kalorama InformationLabs specifically conducted in physician offices are usually not broken out in marketresearch reports covering the diagnostic industry. Numbers are often simply ...The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 7th Edition by KaloramaInformationIn seven best-selling editions, Shara Rosen has provided a total view of every aspect ofthe market for in vitro diagnostic (IVD) testing in one ...See all reports like this >>More Brazil General In Vitro Diagnostics ReportsEmerging In Vitro Diagnostic Markets Bundle: Complete Guides to IVD Distribution inChina, India, Mexico and Brazil by Kalorama Premium In Vitro Diagnostic DatabaseGiven tough competition in developed nations, it should come as no surprise thatcompanies in the in vitro diagnostics IVD market are seeking new markets ...McEvoy and Farmers Complete Guide to IVD Distribution in Brazil by KaloramaPremium In Vitro Diagnostic DatabaseLatin America is one of the areas that IVD companies are looking to for additionalopportunities for IVD products. Among Latin American countries, Brazils population ...IVD Market in BRIC Countries by MarketsandMarketsThe IVD markets of BRIC economies offer immense growth opportunities due to theincreasing healthcare budgets in these nations, along with the increasing number of ...Brazilian Clinical Diagnostics Automation Markets by Frost & Sullivan
  • 5. An overview of the clinical diagnostics automation market in Brazil; analysing separatelythe three automation segments: automated analyzers, stand-alone automation and totallaboratory ...See all reports like this >>More Brazil ReportsD&B Country RiskLine Report: Brazil by Dun & Bradstreet Inc.This D&B Country RiskLine Report will help you analyze the risks, opportunities andlikely payment delays when doing business in this country. It includes ...Country Report Brazil February 2011 by Economist Intelligence UnitCountry Reports analyse political and economic trends in featured countries. They showyou exactly how national, regional and global events will affect your business in ...Country Report Brazil January 2011 by Economist Intelligence UnitCountry Reports analyse political and economic trends in featured countries. They showyou exactly how national, regional and global events will affect your business in ...Country Report Brazil December 2010 by Economist Intelligence UnitCountry Reports analyse political and economic trends in featured countries. They showyou exactly how national, regional and global events will affect your business in ...Country Report Brazil October 2010 by Economist Intelligence UnitCountry Reports analyse political and economic trends in featured countries. They showyou exactly how national, regional and global events will affect your business in ...TABLE OF CONTENTSThere is much discussion about emerging markets in in vitro diagnostics, especially theBRIC nations - Brazil, Russia, India and China. Which companies have been successfulin these markets and how have they accomplished it? What kind of realistic growth canmarketers expect by selling products in these areas? This report is intended to providean overview of trends and developments in the in IVD industry as it applies to emergingmarkets and the BRIC countries in particular. A Realistic Look at the Market for IVD in New, Emerging MarketsA good number of reports on the BRIC and emerging markets have been published.Most of these focus on quantitative data such as number of labs, hospitals, productregistration regulations, and import taxes and conditions. Too many of them perhapspresent merely a growth scenario without presenting the challenges the nations face
  • 6. and the challenges the countries face entering the market. This report provides much ofthis information because it provides an objective overview of the market for in vitrodiagnostics in selected countries. This report also explores the opportunities thatspecific developing countries offer to IVD companies.Kalorama also attempts to add some realistic aspects of working in a foreign countrythat are more qualitative in nature. Thus the report explores some of the culturalaspects of how the market for clinical diagnostics may evolve in a selection of emergingmarkets including the BRIC countries. Useful Information for Business PlanningThe discussion of each of the BRIC markets begins with a short introduction to thecountry and follows with a SWOT analysis of the market for IVDs. The SWOT analysisprovides positive and negative aspects of market conditions. The author has decided toinclude positive and negative aspects of certain factors in the same SWOT category.The factors are classed positive or negative according to the strength of current marketconditions. This is done to make the analysis comprehensive and easier to read. Thereport covers data trends and issues, including: Healthcare trends and metrics in each country Physician Office Testing (POL) in BRIC Countries Disease Trends ( Diabetes, Cancer, Allergy, Emerging Viruses ) Lab Systems in BRIC Countries SWOT Analysis for Each BRIC Nation, Including: o Strengths - factors that make the country attractive for IVD companies o Weaknesses that form barriers to entry and success such as health insurance coverage, regulatory affairs and distribution issues o Country Elements that Provide Testing Opportunities o Threats - a look at the competition and incumbents Key Companies Operating in Each Country Research and High Technology in BRIC countries Other Trends (Insurance, Medical Tourism, Recession Effects )Market and economic trends are discussed from the point of view of their present andpotential impact and there is a focus on the mix of economics, healthcare anddiagnostics that may evolve in these countries. Beyond BRICWith all the attention directed at the BRIC countries, there is a tendency to think thatthey are the only prospects for IVD market growth and development. The fact is thatsome of the same trends - growing middle class, mix of infectious and non-communicable diseases and government supported healthcare - are prevalent in manycountries in E. Europe and Africa. We provide as an example three non-BRIC nations:
  • 7. Turkey, Poland and Nigeria, where IVD may flourish in the future. From Kalorama Information, a Respected Source for IVD Market AnalysisAuthored by Shara Rosen, R.T. MBA, the author of The Worldwide Market for In VitroDiagnostics, in seven editions, This report explores some of the quantitative andqualitative aspects of emerging markets but leaves conclusions up to the readers, whocan best judge how their individual company culture and strategic aspirations fit withprospects in emerging countries. The information contained here provides an overviewof the general economic and infrastructure information related to emerging markets. Theinformation presented in this report is derived from publicly available informationsources such as company, government, and medical organization reports. The analysisis based on the authors industry knowledge combined with literature searches andinterviews with industry professionals and experts in in vitro diagnostics. TABLE OF CONTENTSCHAPTER ONE: EXECUTIVE SUMMARY Scope and Methodology Emerging Market Trends World Demand for DiagnosticsCHAPTER TWO: INTRODUCTION Background Population Trends and Disease Demographics Disease Trends o Diabetes o Cancer o Allergy o Emerging Viruses Market Segment Opportunities o Physician Office Testing (POL) o Lab Systems o Research and High Technology Insurance Trends Medical Tourism Recession EffectsCHAPTER THREE: OVERVIEW AND BRIC COMPARISON Background The BRIC Metrics o Available Market o Culture of Paying for Healthcare o Capacity to Serve
  • 8. IVD Spending China and India - The BRIC EnginesCHAPTER FOUR: CHINA: MARKET TRENDS/DEMAND ANALYSIS Introduction Strengths - Factors That Make the Country Attractive Weaknesses - Factors That Offer Barriers to Market Success and Entry o Insurance o Regulatory Affairs o Distribution Issues Opportunities - Elements That Provide Opportunity Threats - competition and incumbent players o The Market o International IVD Companies o Bayer Diabetes Care o Biohit Oy o Cogenics (now part of Danaher) o Eiken Chemical Co., Ltc o Fenwal, Inc. o IRIS International, Inc. o Luminex Corporation o MedMira o m-u-t AG o PerkinElmer o Phadia AB o QIAGEN N.V. o Quest Diagnostics o Quintiles o Roche Diagnostics o SuperNova Diagnostics, Inc. o China-based Companies o Autobio Group o Beijing Genome Institute (BGI) o Bio-Asia Diagnostics o CapitalBio Corporation o Caretium Medical Instruments o Chemtron Biotech Co. Ltd o China Health Labs & Diagnostics Ltd. o China Medical Technologies o China Sky One Medical, Inc. o Hai Kang Life Corporation o Mindray Medical International Limited o Motic o ProGenTech Limited o Runbio Biotech Co. Ltd.
  • 9. o Shanghai Kehua Bio-Engineering o Vita GenomicsCHAPTER FIVE: INDIA: MARKET TRENDS/DEMAND ANALYSIS Introduction Strengths - factors that make the country attractive o No Centralized Decision Makers o Insurance o Regulatory Affairs o Distribution Issues Opportunities - elements that provide opportunity Threats - competition and incumbent players o The Market o International IVD Companies o Biomagnetics Diagnostics Corp. o DiaGenic o Novartis Diagnostics o PerkinElmer o Phadia AB o QIAGEN N.V. o Quest Diagnostics o Quintiles o Radient Pharmaceuticals Corp. o India-Based Companies o 3B BlackBio India Biotech o Agappe Diagnostics o AGD Biomedicals Pvt. Ltd. o Avesthagen Limited o Diagnova o J.Mitra & Co. Pvt Ltd o ROBONIK INDIA PVT LTD o Span Diagnostics Ltd. o Transasia Bio-Medicals Ltd. o Trivitron Group o The Tulip Group o Vimta LabsCHAPTER SIX: BRAZIL: MARKET TRENDS/DEMAND ANALYSIS Introduction Strengths - factors that make the country attractive Weaknesses - factors that offer barriers to market success and entry o Insurance o Regulatory Affairs o Distribution
  • 10. Opportunities - elements that provide opportunity Threats - competition and incumbent players o The Market o International IVD Companies o Agendia B.V. o AnaSpec, Inc. o Axela Inc. o Chembio Diagnostics Inc. o Fluidigm Corporation o Genomic Health, Inc. o Hemagen Diagnostics, Inc o Phadia AB o Brazil-based Companies o Bio-Manguinhos/FioCruz o BIOTÉCNICA Indústria e Comércio Ltda o CELM - Companhia Equipadora De Laboratorios Modernos o Doles Reagentes o Ebram Productos Laboratorias o Gold Analisa o Hemogram Indústria e Comercio de Produtos Hospitalares o Katal Biotechnologica/Interteck o Laborlab o Wama DiagnosticaCHAPTER SEVEN: RUSSIA: MARKET TRENDS/DEMAND ANALYSIS Introduction Strengths - Factors that make the Country Attractive Weaknesses - Factors that Offer Barriers to Market Success and Entry o Insurance o Regulatory Affairs o Distribution Issues Opportunities - Elements That Provide Opportunity Threats - Competition and Incumbent Players o The Market o International IVD Companies o Arrayit Corp. o Biohit Oy o Russia-based Strength o Alkor Bio o Biola o Dialat Ltd. o Evrogen JSC o InterLabService Ltd. (ILS) o Olveks Diagnostikum o Technomedica
  • 11. o Vital Diagnostics SPb o Xema-Medica Co., Ltd.CHAPTER EIGHT: NATIONS OTHER THAN BRIC Introduction Turkey Poland NigeriaCHAPTER NINE: CONCLUSION Introduction Insurance Intellectual Property Protection Regulatory Affairs & Distribution Market Opportunities TABLE OF EXHIBITSCHAPTER ONE: EXECUTIVE SUMMARY Figure 1-1 IVD Market in BRIC Nations Table 1-1: In Vitro Diagnostic Reagent, BRIC countries 2009-2014, $ million Table 1-2: Market Conditions in Developing Countries Table 1-3: Worldwide In Vitro Diagnostic Reagent Sales by Country/Region 2009-2014,CHAPTER TWO: INTRODUCTION Table 2-1: Selected Disease Statistics, Worldwide, 2008 Table 2-2: Elderly Support Ratio in Selected Countries (2050) Table 2-3: Overview of Physician Office Labs by Country Table 2-4: Labs in the BRIC Countries Table 2-5: Medical Cost Increases, Worldwide, 2006-2008CHAPTER THREE: OVERVIEW AND BRIC COMPARISON Table 3-1: Available Market Data, 2009 Table 3-2: Healthcare Expenditure History Table 3-3: Healthcare Infrastructure Capacity Table 3-4: IVD Expenditure per person, 2009 Table 3-5: BRIC IVD sales, 2009-2014 Table 3-6: Infrastructure data for major markets, 2005-2006CHAPTER FOUR: CHINA: MARKET TRENDS/DEMAND ANALYSIS
  • 12. Table 4-1: Selected Disease Prevention Programs Table 4-2: Selected Preventative Medicine Opportunities Table 4-3: IVD Market Segmentation, China 2009, percent dollar sales Table 4-4: Company Market Share Data, 2009 Table 4-5: Selected IVD Manufacturers in ChinaCHAPTER FIVE: INDIA: MARKET TRENDS/DEMAND ANALYSIS Table 5-1: Key Drivers for Healthcare in India Table 5-2: IVD Market Segmentation, India 2009, percent dollar sales Table 5-3: Company Market Share Data, 2009CHAPTER SIX: BRAZIL: MARKET TRENDS/DEMAND ANALYSIS Table 6-1: Brief History of Brazil’s Health Reform (1988-2009) Table 6-2: IVD Market Segmentation, Brazil 2009 (Chemistry, Immunoassays, Hematology/Coag, Molecular, Other) Table 6-3: Company Market Share Data, 2009CHAPTER SEVEN: RUSSIA: MARKET TRENDS/DEMAND ANALYSIS Table 7-1: Market Share of Imported Products, by country 2009CHAPTER EIGHT: NATIONS OTHER THAN BRIC Table 8-1:Country Metrics: Turkey, Poland, Nigeria Table 8-2: Major Private Networks in PolandCHAPTER NINE: CONCLUSION Table 9-1: Selected Advanced IVDs in DemandAvailable immediately for Online Download athttp://www.marketresearch.com/product/display.asp?productid=6196828US: 800.298.5699UK +44.207.256.3920Intl: +1.240.747.3093
  • 13. Fax: 240.747.3004

×